Investors Purchase Large Volume of Cameco Put Options (NYSE:CCJ)

Cameco Corporation (NYSE:CCJ) (TSE:CCO) saw some unusual options trading activity on Thursday. Traders acquired 28,210 put options on the stock. This represents an increase of approximately 942% compared to the typical volume of 2,706 put options.

Key Headlines Impacting Cameco

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: GLJ Research reiterated a buy rating on Cameco, supporting upside sentiment from some sell‑side firms that expect continued strength in uranium demand. GLJ Research Reiterates Buy for Cameco (NYSE:CCJ)
• Positive Sentiment: MarketBeat highlighted a bullish, longer-term case that global adoption of nuclear power could keep demand for uranium—and Cameco’s revenues—elevated, a thematic driver that has helped CCJ’s recent run. Can Cameco Continue Its Run?
• Neutral Sentiment: Scotiabank trimmed its FY2027 EPS forecast for Cameco slightly (from $1.53 to $1.48) but left an Outperform rating in place—this is a modest earnings haircut rather than a full-scale outlook change, so the impact may be limited unless revisions accelerate. MarketBeat: Cameco / Scotiabank Note
• Negative Sentiment: Zacks Research downgraded Cameco from “strong-buy” to “hold,” which can pressure momentum players and reduce near-term buying conviction. Zacks.com
• Negative Sentiment: There was unusually large put option activity—roughly 28,210 puts (about a 942% increase vs. average)—indicating elevated hedging or speculative bearish positioning that can amplify intraday volatility and signal downside risk if sentiment shifts. Investors Buy High Volume of Cameco Put Options

Cameco Stock Up 1.8%

Shares of CCJ stock opened at $121.16 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.47 and a quick ratio of 1.85. The stock has a fifty day moving average price of $108.78 and a 200 day moving average price of $93.26. Cameco has a one year low of $35.00 and a one year high of $135.24. The stock has a market cap of $52.77 billion, a P/E ratio of 124.91 and a beta of 0.99.

Cameco (NYSE:CCJ) (TSE:CCO) last posted its earnings results on Friday, February 13th. The basic materials company reported $0.36 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.07. Cameco had a net margin of 17.00% and a return on equity of 9.35%. The business had revenue of $874.57 million for the quarter, compared to analysts’ expectations of $782.13 million. During the same quarter in the previous year, the firm posted $0.36 earnings per share. The firm’s revenue for the quarter was up 1.5% on a year-over-year basis. Analysts predict that Cameco will post 1.27 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CCJ has been the subject of a number of research reports. Glj Research restated a “buy” rating and set a $171.20 target price (up from $100.00) on shares of Cameco in a report on Wednesday. Royal Bank Of Canada increased their price target on shares of Cameco from $150.00 to $160.00 and gave the stock an “outperform” rating in a research report on Tuesday. Zacks Research cut Cameco from a “strong-buy” rating to a “hold” rating in a research report on Wednesday. Raymond James Financial restated an “outperform” rating on shares of Cameco in a research note on Wednesday, January 14th. Finally, Scotiabank reissued an “outperform” rating on shares of Cameco in a research note on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $143.03.

Hedge Funds Weigh In On Cameco

Institutional investors have recently bought and sold shares of the business. Financial Consulate Inc. acquired a new position in shares of Cameco during the third quarter worth approximately $25,000. Nisa Investment Advisors LLC acquired a new stake in shares of Cameco in the 4th quarter valued at approximately $25,000. Founders Capital Management bought a new position in shares of Cameco during the fourth quarter worth $27,000. Strategic Advocates LLC bought a new position in Cameco during the third quarter worth about $28,000. Finally, Mcguire Capital Advisors Inc. acquired a new position in shares of Cameco in the 4th quarter valued at approximately $28,000. Institutional investors own 70.21% of the company’s stock.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.